Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7401–7450 of 18424
Further, on November 17, 2023, Mr. Dan Lamadrid, age 48, was appointed as the Company’s Executive Vice-President & Chief Financial Officer, effective December 18, 2023.
Mr. John Faieta , who has been serving as the Company’s interim Chief Financial Officer while Mr. Agarwal was on administrative leave , will become the Company’s new Chief Financial Officer effective immediately.
terminated the employment of Rahul Agarwal, the Company’s Chief Financial Officer, effective immediately
Donald H. Goree resigned from his position as HNRA’s Chief Executive Officer, Chief Financial Officer, Chairman, and Director
On November 20, 2023, the Company’s board of directors appointed Keith Terreri as the Company’s Chief Financial Officer, effective December 4, 2023.
Effective November 17, 2023, OmniQ Corp’s. (the “Company”) Chief Financial Officer (CFO), Niv Nissenson resigned from his position as CFO for personal reasons.
The interim CFO will be the Company’s CEO, Shai Lustgarten.
On November 17, 2023, CytoDyn Inc., a Delaware corporation (the “Company”), entered into an employment agreement with. Jacob P. Lalezari, M.D. (the “Employment Agreement”), under which he will be employed as the Company’s interim CEO on an at-will basis, effective November 17, 2023.
On November 20, 2023, in connection with the Dissolution, Simba Gill ceased serving as the Company’s President, Chief Executive Officer, principal executive officer and president, and Marella Thorell ceased serving as the Company’s Chief Financial Officer, Secretary, Treasurer, principal financial officer and principal accounting officer, in each case, effective as of 11:59 p.m., Eastern Time, on November 20, 2023.
On November 20, 2023, in connection with the Dissolution, Simba Gill ceased serving as the Company’s President, Chief Executive Officer, principal executive officer and president, and Marella Thorell ceased serving as the Company’s Chief Financial Officer, Secretary, Treasurer, principal financial officer and principal accounting officer, in each case, effective as of 11:59 p.m., Eastern Time, on November 20, 2023.
The Company also announced that Kevin S. Murphy, President of the Company, was appointed to serve as the Company’s Chief Executive Officer, and John L. Goff, Jr., Senior Vice President of Retail Operations, was appointed to serve as the Company’s President, each effective as of January 1, 2024.
Effective November 10, 2023, Mr. Cravens’ employment with the Company ended.
On November 6, 2023, the Company announced the appointment of Mr. Matt Reback as President and Chief Executive Officer, effective November 13, 2023
On November 14, 2023, Mark Heinen notified Better Therapeutics, Inc. (the “Company”) of his resignation as the chief financial officer of the Company, effective November 27, 2023.
On November 20, 2023, Centrus Energy Corp. (the “Company”) announced the transition of Chief Executive Officer from Daniel B. Poneman to Amir Vexler effective January 1, 2024.
on November 16, 2023, the Board of Directors (the “Board”) of the Company appointed Amir Vexler, age 50, to succeed Mr. Poneman as Chief Executive Officer of the Company, effective January 1, 2024.
On November 17, 2023, the Board appointed Lawrence Coben, 65, to the position of interim president and chief executive officer (“Interim CEO”), effective immediately.
He succeeds Mauricio Gutierrez, who resigned as the Company’s Chief Executive Officer and President and as a member of the Board, effective November 17, 2023.
Ms. Duffy will replace Christopher J. Bilotto who has resigned as our President and Chief Executive Officer, effective December 31, 2023
Jennifer F. Francis, who is retiring from RMR on June 30, 2024, and therefore has resigned as our President and Chief Executive Officer, effective December 31, 2023.
On November 17, 2023, our Board of Trustees, or the Board, appointed Christopher J. Bilotto as our President and Chief Executive Officer, effective January 1, 2024.
On November 17, 2023, Mr. Lurier ceased serving as the Company’s Interim Chief Financial Officer and Principal Financial and Accounting Officer
Juan Vera, the Company’s President and Chief Executive Officer, was appointed as the Company’s Principal Financial and Accounting Officer.
at which date Jeremy B. Ford will become Chief Executive Officer of PlainsCapital Bank.
Jerry Schaffner, President and Chief Executive Officer of PlainsCapital Bank, notified Hilltop Holdings Inc., or the Company, that he will retire effective May 1, 2024.
On November 17, 2023, each of Chris Schelling, Acer’s President and Chief Executive Officer, and Harry S. Palmin, Acer’s Chief Financial Officer, ceased to be an executive officer of Acer.
On November 17, 2023, each of Chris Schelling, Acer’s President and Chief Executive Officer, and Harry S. Palmin, Acer’s Chief Financial Officer, ceased to be an executive officer of Acer.
On November 17, 2023, the Company’s Chief Financial Officer, Ramon A. Pino (“Mr. Pino”), stepped down as Chief Financial Officer of the Company
The Company’s Board of Directors appointed Thomas E. Vickers (“Mr. Vickers”), Chairman of the Board, as Interim Chief Financial Officer until a permanent successor Chief Financial Officer is appointed.
On November 15, 2023, Michael R. Leach, Senior Vice President and Chief Financial Officer for Allient Inc. (the “Company”), informed the Company of his intent to retire from the Company on April 30, 2024.
On November 16 , 2023, Greenidge Generation Holdings Inc. (the “Company”) appointed one of its members of its Board of Directors (the “Board”), Jordan Kovler, as its new Chief Executive Officer ("CEO")
Concurrently therewith, FU Wah, the Company’s Chief Executive Officer, Secretary and Director, was appointed to serve as the Chief Financial Officer and fill the vacancy caused by Mr Lau’s removal.
Effective November 20, 2023, LAU Ping Kee was removed from his position as Chief Financial Officer of King Resources, Inc. (the “Company”).
the Board of Directors (the “Board”) of PepsiCo, Inc. (“PepsiCo”) appointed James (“Jamie”) Caulfield as PepsiCo’s Executive Vice President and Chief Financial Officer, effective November 30, 2023.
the appointment of Ryan J. Soroka to the positions of Senior Vice President and Chief Financial Officer (in addition to his current role as Chief Accounting Officer), effective November 15, 2023.
The Company plans for Mr. Smalley to succeed Ronald N. Tutor as Chief Executive Officer of the Company effective January 1, 2025, with Mr. Tutor transitioning to the role of Executive Chairman of the Company’s Board at that time
On November 13, 2023, Michael Jensen, Chief Financial Officer of Synlogic, Inc. (the “Company”) resigned from his role as Chief Financial Officer of the Company, effective December 1, 2023 (the “Departure Date”).
and appointed him as its new Chief Executive Officer.
On November 1, 2023, Anthony Lombardo resigned as Chief Executive Officer of Mountain Top Properties, Inc. (the “Company”).
appointed Les Funtleyder as Chief Financial Officer and principal financial officer of the Company, effective as of November 20, 2023
the Board appointed Paul S. Lalljie, the Company’s current Chief Financial Officer, to succeed Mr. Paucek as Chief Executive Officer of the Company and as a member of the Board, effective as of the Transition Date.
Matthew J. Norden, the Company’s current Chief Legal Officer, was appointed to the role of Chief Financial Officer, effective as of the Transition Date.
will be departing from the role of Chief Executive Officer and resigning as a member of the Board, effective as of November 16, 2023
On November 13, 2023, Chicago Rivet & Machine Co. (the “Company”) announced Joel M. Brown as the new Chief Financial Officer of the Company effective immediately.
On November 15, 2023, Andrew Hurst resigned as President and Chief Executive Officer of the Company and as a director of the Company, effective immediately.
On November 17, 2023, Perdoceo Education Corporation (the “ Company ”) announced that, effective November 16, 2023 (the “ Transition Date ”), Todd Nelson has been appointed as President and Chief Executive Officer of the Company and transitioned from his position of Executive Chairman of the Board of Directors (the “ Board ”) to fill such offices.
Scott D. Sheffield will retire as the Company’s Chief Executive Officer effective as of the end of day on December 31, 2023.
Mr. Dealy’s compensation in connection with his previously announced appointment as the Company’s Chief Executive Officer effective January 1, 2024
On November 15, 2023, the Company’s Board appointed Gerald Bruce as CEO and Dr. Eric Floyd as Chair of the Board, effective as of November 20, 2023.
On November 15, 2023, Virpax Pharmaceuticals, Inc. (the “Company”) accepted the resignation of Anthony P. Mack as Chief Executive Officer (“CEO”) and Chair of the Board of Directors (the “Board”) of the Company effective November 17, 2023.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.